At Aliya Health Group, we understand that finding relief from depression is not always a straightforward path. For individuals who have not responded to traditional medications, we offer a specialized intervention: Spravato® (esketamine). This FDA-approved nasal spray represents a significant advancement in interventional psychiatry, providing a new option for adults navigating treatment-resistant depression (TRD).
Depression affects everyone differently, and standard treatments do not work for everyone. If you have tried multiple antidepressants without success, Spravato® may offer the breakthrough you need. Unlike conventional oral antidepressants, which primarily target serotonin and dopamine, esketamine targets the N-methyl-D-aspartate (NMDA) receptor. This unique mechanism helps repair neural connections in the brain, offering the potential for symptom relief where other methods have failed.
Insurance providers widely recognize Spravato® as a gold-standard treatment, often providing reimbursement coverage that makes this scalable service accessible to many of our clients.
Treatment-resistant depression (TRD) is a form of major depressive disorder that does not improve after trying at least two different antidepressant medications, taken at the right dose and for a long enough time.
In other words, a person with TRD continues to experience significant depressive symptoms even after standard treatments have been followed correctly.
Several factors can contribute, including:
No one should have to wait to heal, which is why our specialists are available 24/7 to help guide you through the admissions process every step of the way.
Our Spravato® program is specifically designed for adults facing complex mental health challenges. Eligibility typically requires that you:
Patient safety is our top priority. Spravato® is not indicated for patients with bipolar disorder, schizophrenia, or a history of aneurysms, stroke, or brain injury. Our clinical team conducts a comprehensive medical assessment to ensure this treatment is safe and appropriate for your specific needs.
Spravato® therapy follows a specific schedule that tapers over time based on how well you respond to the medication:
We believe the setting is just as important as the medication. We have curated a treatment environment designed to reduce anxiety and promote therapeutic benefit. Our sessions are held in a calming space where you can utilize headphones and listen to a curated ketamine playlist. This supportive atmosphere helps you relax and focus entirely on your recovery journey.
Recovery doesn’t end when the session concludes. At Aliya Health Group, we are committed to patient-centered care that extends beyond our immediate program. We coordinate comprehensive aftercare plans to ensure you can continue Spravato® treatments after discharge if necessary, supporting your long-term stability and sustained wellness.
If you are ready to explore a new avenue for treating depression, we are here to help. Contact Aliya Health Group to discuss your eligibility for Spravato® and take the next step toward a healthier future.
Don’t see your insurance? Don’t worry!
Aliya Health Group works with most major providers to help you gain access to quality detox and rehab services.
If you are ready to explore a new avenue for treating depression, we are here to help. Contact Aliya Health Group to discuss your eligibility for Spravato® and take the next step toward a healthier future.
We’re here to answer any of your questions about mental health treatment options near you.
Give us a call today at 888-973-2078.
